CI
IART icon

Cordant Inc’s Integra LifeSciences IART Stock Holding History

Cordant Inc’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-28
Closed -$2K – 611
2022
Q1 		$2K Buy
+28
New +$1.84K ﹤0.01% 669
2021
Q4 		– Sell
-13
Closed -$1K – 196
2021
Q3 		$1K Buy
+13
New +$918 ﹤0.01% 262

Other funds holding IART

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cordant Inc's IART Position: Q2 2022 in Review

Cordant Inc sold out of Integra LifeSciences (IART) in Q2 2022, closing a stake of 28 shares — an estimated $2K sold.

Cordant Inc first reported a position in IART in Q3 2021 and held it in 2 quarters. The position peaked at $2K in Q1 2022. 284 funds tracked by Wall St. Rank hold IART as of Q2 2022.

  • Cordant Inc reported no remaining Integra LifeSciences position as of Q2 2022 after selling out during the quarter.
  • Cordant Inc sold 28 Integra LifeSciences shares in Q2 2022, an estimated $2K.
  • Cordant Inc first reported a position in Integra LifeSciences in Q3 2021 and held it in 2 quarters.
  • Cordant Inc's Integra LifeSciences position peaked at $2K in Q1 2022.
  • 284 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2022.

Based on Cordant Inc's 13F filing for Q2 2022, filed 17 Aug 2022.